Pytte M, Dybwik K, Sexton J, Straume B, Nielsen E Waage
Department of Anaesthaesiology and Intensive Care, Ulleval University Hospital, Oslo, Norway.
Acta Anaesthesiol Scand. 2006 Jul;50(6):718-21. doi: 10.1111/j.1399-6576.2006.01045.x.
Norepinephrine is frequently used in intensive care unit (ICU) patients to raise and maintain an adequate mean arterial pressure (MAP). Conflict arises as to which MAP should guide vasopressor dose, as oscillometric MAP in the brachial artery often diverges from intra-radial MAP. We wanted to estimate the magnitude of this difference in ICU patients receiving norepinephrine, and to see whether the patient age, norepinephrine dose, age of radial catheter, ventilation treatment or severity of illness influenced the difference.
Prospective observational study comparing oscillometric MAP and intra-radial MAP performed in a central hospital-based surgical ICU during the period from February 2002 through to October 2003. Sixty-eight consecutive patients who received a norepinephrine infusion to maintain MAP above 70 mmHg were included. The mean arterial blood pressure was measured both oscillometrically and in the ipsilateral radial artery.
Oscillometric MAP was on average 6.6 mmHg higher (95% CI 5.3-7.9) than intra-radial MAP in the 134 sets of measurements (P < 0.001). The patient's age (P = 0.319), norepinephrine dosage (P = 0.959) the age of the radial catheter (P = 0.992) were not significant. The difference in MAP was marginally greater in ventilated patients (P = 0.061) and significantly greater as the simplified acute physiology score (SAPS) score increased (P = 0.022).
MAP measured oscillometrically over the brachial artery directly in the radial artery gave different results in an ICU population receiving norepinephrine. In more than one of four patients this difference is so large, and increases with illness severity, that the selection of any one method would influence treatment.
去甲肾上腺素常用于重症监护病房(ICU)患者以升高并维持足够的平均动脉压(MAP)。由于肱动脉示波法测量的MAP常与桡动脉内MAP存在差异,对于应以何种MAP来指导血管升压药剂量的问题存在争议。我们旨在评估接受去甲肾上腺素治疗的ICU患者中这种差异的程度,并观察患者年龄、去甲肾上腺素剂量、桡动脉导管使用时长、通气治疗或疾病严重程度是否会影响这种差异。
2002年2月至2003年10月期间,在一家中心医院的外科ICU进行了一项前瞻性观察研究,比较肱动脉示波法测量的MAP和桡动脉内MAP。纳入68例连续接受去甲肾上腺素输注以维持MAP高于70 mmHg的患者。同时采用示波法和同侧桡动脉穿刺法测量平均动脉血压。
在134组测量中,示波法测量的MAP平均比桡动脉内MAP高6.6 mmHg(95%可信区间5.3 - 7.9)(P < 0.001)。患者年龄(P = 0.319)、去甲肾上腺素剂量(P = 0.959)、桡动脉导管使用时长(P = 0.992)对差异无显著影响。通气患者的MAP差异略大(P = 0.061),且随着简化急性生理学评分(SAPS)的增加差异显著增大(P = 0.022)。
在接受去甲肾上腺素治疗的ICU患者中,通过肱动脉直接示波法测量的MAP与桡动脉内测量结果不同。超过四分之一的患者中这种差异很大,且随疾病严重程度增加,选择任何一种测量方法都会影响治疗。